版本:
中国

BRIEF-Celgene & Agios collaborates with Abbott to develop diagnostic tests for leukemia

Oct 12 Abbott Laboratories :

* Celgene and Agios announce collaborations with Abbott for diagnostic identification of IDH mutations in AML

* Celgene - companion diagnostic technology to be utilized with Enasidenib, AG-120 development programs for relapsed/refractory acute myeloid leukemia

* Celgene-Agreements with abbott to develop,commercialize companion diagnostic tests on Abbott's M2000 realtime system to identify IDH mutations in AML Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐